Infant HIV Prophylaxis: Risk Group and Nevirapine Dose (WHO Dec 2025, dosing May 2026)
Gives infant HIV prophylaxis by WHO risk group (December 2025).
Open the tool → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- Mother's ART at delivery
- On ART 4 weeks or more
- Mother's viral load in the 4 weeks before delivery
- 1,000 copies/mL or less
- Mother acquired HIV in pregnancy or breastfeeding
- No
- Mother first identified with HIV after delivery
- No
- Breastfeeding
- Yes
- Infant age in weeks
- 0
Result: Not high risk: 6 weeks of single-drug prophylaxis, nevirapine preferred: nevirapine 10 mg/mL 1.5 mL once daily (prophylaxis).
The tool opens with these values already filled in. Replace them with your own.
What you enter
- Mother's ART at delivery
- Mother's viral load in the 4 weeks before delivery
- Mother acquired HIV in pregnancy or breastfeeding
- Mother first identified with HIV after delivery
- Breastfeeding
- Infant age in weeks
- Infant weight in kg (for alternatives)
How this is calculated
Citation
WHO updated recommendations on HIV clinical management. December 2025, section 4.1.1. WHO optimal antiretroviral dosing guidance: paediatric populations. May 6, 2026 (corrigendum June 18, 2026), Table 5. Read the source ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.